BR0104180A - Immune process for the detection of infections by brucella canis bacteria, antigenic extract, application of this extract and diagnostic kit for detecting individuals infected with brucella canis - Google Patents
Immune process for the detection of infections by brucella canis bacteria, antigenic extract, application of this extract and diagnostic kit for detecting individuals infected with brucella canisInfo
- Publication number
- BR0104180A BR0104180A BR0104180A BR0104180A BR0104180A BR 0104180 A BR0104180 A BR 0104180A BR 0104180 A BR0104180 A BR 0104180A BR 0104180 A BR0104180 A BR 0104180A BR 0104180 A BR0104180 A BR 0104180A
- Authority
- BR
- Brazil
- Prior art keywords
- extract
- brucella canis
- bacteria
- infections
- detection
- Prior art date
Links
Landscapes
- Peptides Or Proteins (AREA)
Abstract
Patente de Invenção: "PROCESSO IMUNOLóGICO PARA A DETECçãO DE INFECçõES POR BACTéRIAS DE Brucella canis, EXTRATO ANTIGêNICO, APLICAçãO DESSE EXTRATO E KIT DIAGNóSTICO PARA DETECçãO DE INDIVìDUOS INFECTADOS COM Brucella canis". Processo imunológico para a detecção de infecções por bactérias Brucella canis em um paciente susceptivel a infecção por Brucella canis, que compreende ao menos a etapa de se colocar em contato uma amostra de fluido corporal de dito paciente com um extrato antigênico solúvel de Brucella canis, sendo que o dito extrato compreende pelo menos um grupo de antígenos A) ou B) . O grupo A) consiste em antígenos de peso molecular de 61 kDa e de 55 kDa e o grupo B) consiste em antígenos de peso molecular de 46 kDa, d:e 38 kDa e de 28 kDa. O grupo A) de antígenos é obtido por tratamento das bactérias Brucella canis com calor e o grupo B) de antígenos é obtido por tratamento das ditas bactérias com ultrassom. o extrato antigênico solúvel é utilizado para a preparação de kits e equipamentos de diagnóstico in vitro para detectar infecções por Brucella canis.Invention Patent: "IMMUNOLOGICAL PROCESS FOR THE DETECTION OF INFECTIONS BY BACTERIA OF Brucella canis, ANTIGENIC EXTRACT, APPLICATION OF THIS EXTRACT AND DIAGNOSTIC KIT FOR DETECTION OF INDIVIDUALS INFECTED WITH Brucella canis". Immunological process for the detection of infections by Brucella canis bacteria in a patient susceptible to infection by Brucella canis, which comprises at least the step of contacting a sample of body fluid from said patient with a soluble antigenic extract of Brucella canis, being that said extract comprises at least one group of antigens A) or B). Group A) consists of antigens of molecular weight of 61 kDa and 55 kDa and group B) consists of antigens of molecular weight of 46 kDa, d: and 38 kDa and 28 kDa. Group A) of antigens is obtained by treating the bacteria Brucella canis with heat and group B) of antigens is obtained by treating said bacteria with ultrasound. the soluble antigen extract is used for the preparation of kits and in vitro diagnostic equipment to detect infections by Brucella canis.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ARP010104960 | 2000-09-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0104180A true BR0104180A (en) | 2002-05-28 |
Family
ID=3460908
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0104180A BR0104180A (en) | 2000-09-22 | 2001-09-24 | Immune process for the detection of infections by brucella canis bacteria, antigenic extract, application of this extract and diagnostic kit for detecting individuals infected with brucella canis |
Country Status (1)
Country | Link |
---|---|
BR (1) | BR0104180A (en) |
-
2001
- 2001-09-24 BR BR0104180A patent/BR0104180A/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Van Knapen et al. | Detection of circulating antigen during acute infections with Toxoplasma gondii by enzyme-linked immunosorbent assay | |
BR9916020A (en) | Compounds and methods for the treatment and diagnosis of chlamydia infection | |
Janoff et al. | Diagnosis of Giardia lamblia infections by detection of parasite-specific antigens | |
BRPI0208301A8 (en) | nucleic acid vaccines for prevention of flavivirus infection | |
El-Shazly et al. | Evaluation of ELISA and IHAT in serological diagnosis of proven cases of human hydatidosis | |
Holmgren et al. | Immunological aspects of urinary tract infections | |
Abravanel et al. | Clinical performance of a rapid test compared to a microplate test to detect total anti SARS-CoV-2 antibodies directed to the spike protein | |
El Barrawy et al. | Role of Helicobacter pylori in the genesis of gastric ulcerations among smokers and nonsmokers | |
BRPI0200986B8 (en) | method of determining the presence of hcv in a sample | |
BR0104180A (en) | Immune process for the detection of infections by brucella canis bacteria, antigenic extract, application of this extract and diagnostic kit for detecting individuals infected with brucella canis | |
Gottschalk et al. | Serodiagnosis of swine pleuropneumonia due to Actinobacillus pleuropneumoniae serotypes 7 and 4 using long-chain lipopolysaccharides. | |
HK1050728A1 (en) | Compositions and methods for detecting treponema pallidum. | |
El-Badry et al. | Molecular identification & prevalence of Giardia lamblia & Cryptosporidium in duodenal aspirate in Al-Madinah | |
Ashburn et al. | Improved diagnosis of reactivated toxoplasmosis. | |
HANSON et al. | Precipitating antibodies to E. coli O antigens: a suggested difference in the antibody response of infants and children with first and recurrent attacks of pyelonephritis | |
Larin | Studies on the agent of canine virus hepatitis (Rubarth's disease) I. Complement-fixation and precipitin tests | |
Mahajan et al. | Amoebic antigen in immunodiagnosis and prognosis of amoebic liver abscess | |
Jithendran et al. | Comparative evaluation of agar gel precipitation, counterimmunoelectrophoresis and passive haemagglutination tests for the diagnosis of Dicrocoelium dendriticum infection in sheep and goats | |
Youssef et al. | A purified Fasciola gigantica worm antigen for the serodiagnosis of human fascioliasis | |
AR025738A1 (en) | IMMUNOLOGICAL METHOD FOR THE DETECTION OF INFECTIONS WITH THE BUCTERIA BRUCELLA CANIS, AN ANTIGEN EXTRACT AND THE USE OF THE SAME | |
Nandakumar et al. | Diagnosis of typhoid fever: detection of Salmonella typhi porins‐specific antibodies by inhibition ELISA | |
Studahl et al. | Serum S-100B protein levels in patients with herpes simplex encephalitis and tick-borne encephalitis—a marker of CNS damage during the initial stage of disease | |
Militao et al. | Detection of antigens in the urine of patients with acute Plasmodium vivax malaria | |
Wooley et al. | Correlation of cytopathic effect, fluorescent-antibody microneutralization, and plaque reduction test results for determining avian infectious bronchitis virus antibodies | |
WO2011022445A3 (en) | Improved multiplexed, microparticle-based assay for antibodies to antigens |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired |